Tabula Rasa HealthCare — Merger or Acquisition (August 2023)
17 slides from Tabula Rasa HealthCare's merger presentation, Aug 7, 2023
Slide 1: Discussion Materials
Jp TabulaRasa CEXACTCARE HealthCare® Discussion Materials
Slide 2: Disclaimer: Forward-Looking Statements
Disclaimer 2 Forward-Looking Statements This presentation contains “forward-looking statements” that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forwar
Slide 3: Contents: ExactCare Overview
ExactCare Overview Nautic Partners Overview Strategic Rationale for the Transaction Contents 3
Slide 4: A Trusted Pharmacy Care Provider
Founded in 2009 in Cleveland, Ohio Serving patients in all 50 states and Washington D.C. Clinical support staff in 30+ states 750 employees 68,000+ patients in June 2023 6.5M+ scripts in 2022 Long-standing partnerships with payers, providers and other healthcare organizations across the continuum A
Slide 5: Matching Patient Needs to Pharmacy Services
Matching Patient Needs to Pharmacy Services Less Complex Medical Needs Typically well supported by transactional retail counter service Requires little to no assistance with Activities of Daily Living 1 disease state/medical condition 1 active prescriber 4 medications Able to independently manage me
Slide 6: A High-Touch, Comprehensive Approach to Pharmacy
Safer, More Effective Medication Regimens Improved Adherence Better Overall Patient Health Improved Clinical and Quality Metrics Superior Patient Satisfaction Total Cost of Care Savings A High-Touch, Comprehensive Approach to Pharmacy Designed to support the most complex, highest-cost patients at ho
Slide 7: Strong Partnerships Across the Healthcare Continuum
Strong Partnerships Across the Healthcare Continuum
Slide 8: Consistently Strong Service Ratings
8 Based on the industry best practice for measuring Net Promoter Score (NPS) Annual survey for established patients NPS based on the question, “Would you recommend ExactCare to your family and friends?” NPS results range from -100 to +100 +1 or higher is “good” +50 to +69 is “excellent” +70 or highe
Slide 9: Proven Clinical and Financial Outcomes
Proven Clinical and Financial Outcomes Findings Consistent With Other Studies Study Year Total Cost of Care Savings Client A - Medicaid 2020 $218 PMPM Client B - Medicaid 2020 $239 PMPM Optum - Medicaid 2018 $496 PMPM Optum - Medicare 2018 $731 PMPM Optum - Duals 2018 $980 PMPM A RAND study of Exact
Slide 10: Contents: Nautic Partners Overview
ExactCare Overview Nautic Partners Overview Strategic Rationale for the Transaction Contents 10
Slide 11: Nautic Partners Overview
Nautic Partners Overview Nautic and its predecessor, Fleet Equity Partners, have completed over 150 private equity transactions since 1986 Have managed over $9.5 billion in equity capital over our history 29 active portfolio companies and 125 realized investments Seasoned staff of 34 investment prof
Slide 12: Our Approach
Our Approach Find opportunities where we have relevant experience and strong track record and that fit with our thematic areas of interest Bring partnership approach to all our investments – ensure aligned vision with management, employees, and clients Do no harm – respect what has been built; take
Slide 13: Relevant Experience
Relevant Experience Multiple current and former portfolio companies with extensive VBC capabilities including global capitation 13 Value Base Care Wide range of pharmacy, benefit management, and pharma services experience aligned with serving complex patient populations and reducing total medical ex
Slide 14: Contents: Strategic Rationale for the Transaction
ExactCare Overview Nautic Partners Overview Strategic Rationale for the Transaction Contents 14
Slide 15: Compelling Strategic Rationale for Combination
Opportunity to Significantly Expand TAM Expanding Referral Patterns and End Markets Builds a National Platform with an Unparalleled Clinician Team Servicing Patients in all 50 States Combined Track Record of High Quality Service and Excellent Customer Satisfaction Access to Best-in-Class Management
Slide 16: Combined company comparison: patients, revenue, services
2023E Patients ~74,000 ~21,000 ~95,000 2023E Rx and Rx Per Patient ~7.0M / ~95 ~3.0M / ~150 ~10.0M / ~105 2022 Revenue ~$500M ~$300M ~$800M Services Offered Polychronic pharmacy; MTM / Other Clinical Services; 340B contract pharmacy PACE pharmacy and PBM; MedWise; Risk adjustment; TPA and EHR Full s
Slide 17: Significant Opportunity to Expand Market Opportunity
Significant Opportunity to Expand Market Opportunity 17 Current Tabula Rasa Combined Company As a combined company, ExactCare and Tabula Rasa will be able to deliver a broader range of services to a wider range of patient populations through different channels Market Opportunity Patient Population 6
Tabula Rasa HealthCare — Merger or Acquisition (August 2023) on 6ix